Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up since Aug 6 · above the Ichimoku cloud · RSI 58 · MACD above its signal
None of the 29 investors followed here reported a position in ACB.TO in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 24, 2026 | King (Simona)Senior Officer of Issuer | — | 25.6K | — |
| Jun 24, 2026 | King (Simona)Senior Officer of Issuer | Exercise of rights at price 2.77 per share. | 8K | $22.11K |
| Jun 24, 2026 | Martin (Miguel)Senior Officer of Issuer | — | 73K | — |
| Jun 24, 2026 | Schick (Lori)Senior Officer of Issuer | — | 16.2K | — |
| Jun 24, 2026 | Schick (Lori)Senior Officer of Issuer | Exercise of rights at price 2.77 per share. | 9K | $25.00K |
| Dec 30, 2025 | Miller (Alex)Senior Officer of Issuer | — | 2.3K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.5 | -5.1 | -12.4 | 2.0 | 6.2 | -20.4 | -1.8 | 45.1 | -1.2 | 9.5 | +5.5% | ||
| 2025 | -13.6 | 39.6 | -14.5 | 1.3 | 13.9 | -20.8 | 6.6 | 20.5 | 12.3 | -16.2 | -7.6 | -10.3 | −5.6% |
| 2024 | -20.0 | -17.9 | 38.9 | 113.3 | -33.4 | -24.9 | 33.9 | -3.4 | -2.6 | -5.3 | -15.3 | -4.4 | −6.0% |
| 2023 | 11.2 | -18.7 | -16.8 | -16.0 | -13.9 | 2.9 | 7.1 | -10.7 | 17.9 | -22.8 | 1.6 | 4.8 | −48.0% |
| 2022 | -22.5 | -9.2 | 3.3 | -21.7 | -45.4 | -20.2 | 6.5 | 17.1 | -20.8 | 16.7 | -11.7 | -27.7 | −81.8% |
| 2021 | 33.8 | -5.1 | -13.2 | -6.3 | 2.6 | -0.1 | -22.0 | 6.8 | -6.3 | -6.4 | 0.0 | -16.6 | −35.4% |
| 2020 | -10.4 | -27.6 | -30.4 | -19.0 | 57.4 | -12.9 | -18.7 | -5.6 | -51.9 | -13.2 | 183.5 | -30.5 | −68.3% |
| 2019 | 37.2 | 6.7 | 21.9 | 0.7 | -15.6 | -0.1 | -19.7 | -10.9 | -20.7 | -18.9 | -29.7 | -16.0 | −58.8% |
| 2018 | 21.9 | -11.1 | -10.6 | -13.0 | 0.5 | 14.4 | -24.5 | 25.4 | 41.0 | -28.0 | -15.0 | -10.8 | −29.4% |
| 2017 | -1.3 | 12.3 | 1.2 | 0.0 | -9.3 | -7.7 | 24.5 | -7.4 | 11.6 | 9.7 | 162.3 | 20.0 | +317.4% |
| 2016 | 20.8 | -13.9 | +4.1% |
No member of Congress has disclosed a ACB.TO trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes Aurora, Being, CanniMed, CraftPlant, Daily Special, Drift, Greybeard, IndiMed, MedReleaf, Pedanios, San Raf, Tasty's, Whistler, and WMMC. The company also engages in pharmacy activities. Aurora Cannabis Inc. was founded in 2013 and is headquartered in Edmonton, Canada.
Buy / hold / sell counts
No recent headlines.